Imunon Inc (NASDAQ:IMNN) does about 11.09M shares in volume on a normal day but saw 1776037 shares change hands in the recent trading day. The company now has a market cap of 16.26M USD. Its current market price is $0.8, marking an increase of 8.11% compared to the previous close of $0.74. The 52 week high reached by this stock is $3.65 whilst the lowest price level in 52 weeks is $0.37.
The consensus objective for the share price is $11.25, suggesting that the stock has a potential upside of 92.89% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is -38.26%, -25.98%, and -16.50% away from its SMA20, SMA50, and SMA200 respectively, with the IMNN price moving above the 50-day SMA on current market day. Imunon Inc (IMNN) stock is down -13.21% over the week and -59.80% over the past month. Its price is -27.93% year-to-date and -15.79% over the past year.
To reach the target analysts have set, the stock logically needs to grow 92.89 percent from here.
Outstanding shares total 20.32M with insiders holding 6.44% of the shares and institutional holders owning 1.61% of the company’s common stock. The company has a return on investment of -1670.41% and return on equity of -397.54%. The beta has a value of 1.93. Price to book ratio is 25.87.
